To explore the potential synergistic effects of autophagy inhibition and immune checkpoint blockade, we initiated combination treatment with SBI-0206965 and an anti-mouse PD-1 (CD279) antibody in a CT26 subcutaneous tumor model. This evidence concerns the gene PDCD1 and neoplasm.